It is possible new templates exist for this target since these models were created.
Available Structures
37 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
HUMAN ESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH KB095285 AND CIA12 COACTIVATOR P… |
Heteromer Q9HCD5; | 2×KB0; | ||||
Assess | ||||||
Crystal Structure of Estrogen Receptor beta complexed with WAY-338 |
Heteromer Q15788; | 2×338; | ||||
Assess | ||||||
Crystal Structure of Estrogen Receptor Beta Complexed with WAY-555 |
Heteromer Q15788; | 2×555; | ||||
Assess | ||||||
Crystal structure of estrogen receptor beta complexed with 3-Bromo-6-hydroxy-2-(4-hydroxy-phenyl)-i… |
Heteromer Q15788; | 2×789; | ||||
Assess | ||||||
Crystal structure of phosphorylated estrogen receptor beta ligand binding domain |
Heteromer Q15788; | 1×EST; | ||||
Assess | ||||||
Human Estrogen Receptor beta Ligand-binding Domain in Complex with S-DPN |
Heteromer Q15788; | 2×I0K; | ||||
Assess | ||||||
Human Estrogen Receptor beta Ligand-binding Domain in Complex with (R)-2-(2-chloro-4-hydroxyphenyl)… |
Heteromer Q15788; | 2×I1M; | ||||
Assess | ||||||
Human Estrogen Receptor beta Ligand-binding Domain in Complex with (S)-3-(2-chloro-4-hydroxyphenyl)… |
Heteromer Q15788; | 2×I1I; | ||||
Assess | ||||||
Human Estrogen Receptor beta Ligand-binding Domain in Complex with (R)-3-(2-chloro-4-hydroxyphenyl)… |
Heteromer Q15788; | 2×I1D; | ||||
Assess | ||||||
Human Estrogen Receptor beta Ligand-binding Domain in Complex with (S)-2-(2-chloro-4-hydroxyphenyl)… |
Heteromer Q15788; | 2×I2B; | ||||
Assess | ||||||
Stapled peptide bound to Estrogen Receptor Beta |
Heteromer Q15596; | 2×YJD; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-697 |
Heteromer Q15788; | 2×697; | ||||
Assess | ||||||
Crystal Structure of Estrogen Receptor beta complexed with WAY-797 |
Heteromer Q15788; | 2×797; | ||||
Assess | ||||||
Crystal structure of estrogen receptor beta complexed with 1-chloro-6-(4-hydroxy-phenyl)-naphthalen… |
Heteromer Q15788; | 2×4NA; | ||||
Assess | ||||||
Fragment-Based Design of novel Estrogen Receptor Ligands |
Heteromer Q15788; | 1×W23; | ||||
Assess | ||||||
Fragment-Based Design of novel Estrogen Receptor Ligands |
Heteromer Q15788; | 1×W14; | ||||
Assess | ||||||
Crystal structure of estrogen receptor beta ligand binding domain |
Heteromer Q15788; | 1×EST; | ||||
Assess | ||||||
Fragment-Based Design of novel Estrogen Receptor Ligands |
Heteromer Q15788; | 1×WV7; | ||||
Assess | ||||||
A second binding site for hydroxytamoxifen within the coactivator-binding groove of estrogen recept… | homo-2-mer | 4×OHT; | ||||
Assess | ||||||
Estrogen receptor beta ligand binding domain in complex with a Benzopyran agonist | homo-2-mer | 2×JJ3; | ||||
Assess | ||||||
HUMAN OESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH PARTIAL AGONIST GENISTEIN | homo-2-mer | 2×GEN; | ||||
Assess | ||||||
Human estrogen receptor beta ligand-binding domain in complex with compound 45 | homo-2-mer | 2×FBR; | ||||
Assess | ||||||
Estrogen receptor beta ligand-binding domain complexed to a benzopyran ligand | homo-2-mer | 2×DC8; | ||||
Assess | ||||||
Estrogen receptor beta ligand-binding domain complexed to a benzopyran ligand | homo-2-mer | 2×3AS; | ||||
Assess | ||||||
Crystal Structure of ER beta bound to Estradiol | homo-2-mer | 2×EST; | ||||
Assess | ||||||
Benzopyrans are Selective Estrogen Receptor beta Agonists (SERBAs) with Novel Activity in Models of… | homo-2-mer | 2×I0G; | ||||
Assess | ||||||
Sulfonamides as selective Estrogen Receptor beta Agonists. | homo-2-mer | 2×SU4; 2×SO4; | ||||
Assess | ||||||
Crystal structure of estrogen receptor beta complexed with way-202196 | homo-2-mer | 2×196; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-244 | homo-2-mer | 2×244; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH ERB-041 | homo-2-mer | 2×041; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH GENISTEIN | homo-2-mer | 2×GEN; | ||||
Assess | ||||||
Crystal Structure of Estrogen Receptor beta complexed with CL-272 | homo-2-mer | 2×272; | ||||
Assess | ||||||
Human Estrogen Receptor beta Ligand-binding Domain in Complex with (R,R)-5,11-cis-diethyl-5,6,11,12… | monomer | 1×ETC; | ||||
Assess | ||||||
Estrogen Receptor beta with Selective Triazine Modulator | monomer | 1×MON; | ||||
Assess | ||||||
Estrogen Receptor in complex with proline-flanked LXXLL peptides | monomer | 1×EST; | ||||
Assess | ||||||
Estrogen Receptor in complex with proline-flanked LXXLL peptides | monomer | 1×EST; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-397 | monomer | 1×397; | ||||
Assess |
14 SWISS-MODEL models
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
7prw.1.A | monomer | 0.61 | 2×ZN; | 30.21 | ||
Assess | ||||||
7prw.1.B | monomer | 0.60 | 2×ZN; | 30.21 | ||
Assess | ||||||
7kw7.1.F | monomer | 0.59 | 30.21 | |||
Assess | ||||||
5uan.1.B | monomer | 0.59 | 1×ZN; | 27.40 | ||
Assess | ||||||
4iqr.2.A | monomer | 0.59 | 2×ZN; | 29.15 | ||
Assess | ||||||
5uan.1.A | monomer | 0.58 | 1×ZN; | 32.93 | ||
Assess | ||||||
4nqa.2.A | monomer | 0.58 | 1×ZN; | 32.93 | ||
Assess | ||||||
4nqa.1.A | monomer | 0.58 | 2×ZN; | 34.88 | ||
Assess | ||||||
4iqr.2.B | monomer | 0.58 | 2×ZN; | 29.15 | ||
Assess | ||||||
4nqa.2.B | monomer | 0.57 | 2×ZN; | 25.58 | ||
Assess | ||||||
4nqa.1.B | monomer | 0.57 | 1×ZN; | 25.58 | ||
Assess | ||||||
3dzy.1.A | monomer | 0.57 | 2×ZN; | 32.42 | ||
Assess | ||||||
3dzy.1.B | monomer | 0.55 | 1×ZN; | 23.10 | ||
Assess | ||||||
7wnh.2.A | monomer | 0.52 | 2×ZN; | 30.19 | ||
Assess |